ResMed | RMD - Umsatzerlöse

Aktienkurs
229.47
Täglich Wechseln
-4.03 -1.73%
Monatlich
-10.46%
Jährlich
3.34%
Q1 Prognose
223.87




Der Umsatz Veränderung Datum
Ansell USD 1.03B 192.2M 2025-12
Artivion USD 115.99M 2.6M 2025-12
AtriCure USD 140.5M 6.2M 2025-12
Baxter International USD 2.97B 130M 2025-12
Cochlear AUD 1.18B 590.35M 2025-12
Cooper Companies USD 1.02B 41.1M 2025-12
CSL USD 8.33B 4.79B 2025-12
Dexcom USD 1.26B 50M 2025-12
Edwards Lifesciences USD 1.57B 20M 2025-12
Fisher Paykel Healthcare NZD 1.1B 21.3M 2025-12
Globus Medical USD 826.4M 57.4M 2025-12
Haemonetics USD 338.97M 11.97M 2025-12
Hologic USD 1.05B 0 2025-12
Idexx Laboratories USD 1.09B 10M 2025-12
Inogen USD 74.93M 504K 2024-09
Insulet USD 783.8M 77.5M 2025-12
Integra LifeSciences USD 434.9M 32.84M 2025-12
Intuitive Surgical USD 2.87B 360M 2025-12
Masimo USD 412.5M 41M 2025-12
Medtronic USD 9B 39M 2026-01
Philips EUR 5.1B 797M 2025-12
Ramsay Health Care AUD 9.34B 82.2M 2025-12
ResMed USD 1.4B 100M 2025-12
Sigma Healthcare AUD 1.68B 188.65M 2024-12
Sonic Healthcare AUD 5.45B 470M 2025-12
Steris USD 1.5B 470M 2025-12
Teleflex USD 568.98M 344.02M 2025-12
Thermo Fisher Scientific USD 12.21B 1.09B 2025-12